<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="34990">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01703520</url>
  </required_header>
  <id_info>
    <org_study_id>0906-162</org_study_id>
    <secondary_id>2003.021</secondary_id>
    <nct_id>NCT01703520</nct_id>
  </id_info>
  <brief_title>An Observational Registry-Based Study of a Potential Link Between Finasteride (MK-0906) and Male Breast Cancer in 4 Nordic Countries (MK-0906-162/2003.021)</brief_title>
  <official_title>A Multinational, Observational Registry-Based Study of a Potential Link Between Finasteride and Male Breast Cancer in 4 Nordic Countries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute for Applied Economics and Health Research Aps</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to investigate the potential association between finasteride
      (MK-0906) exposure and the development of breast cancer in men residing in Denmark, Sweden,
      Finland, and Norway from data in national registries.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Person-Years of Exposure to Finasteride by Participant Age and Year</measure>
    <time_frame>Up to 14 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rates of Male Breast Cancer by Exposure to Finasteride</measure>
    <time_frame>Up to 14 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>All-Cause Mortality Rates in Males with Breast Cancer by Exposure to Finasteride</measure>
    <time_frame>Up to 14 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">270284</enrollment>
  <condition>Male Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Breast Cancer Cases Among Men with No Exposure to Finasteride</arm_group_label>
    <description>The number of new cases of male breast cancer among men with no exposure to finasteride in the registries of Denmark, Finland, Sweden, and Norway.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breast Cancer Cases Among Men with Exposure to Finasteride</arm_group_label>
    <description>The number of new cases of male breast cancer among men exposed to finasteride in the registries of Denmark, Finland, Sweden, and Norway.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Finasteride</intervention_name>
    <description>Prescribed as per routine clinical practice in Denmark, Sweden, Finland, and Norway.</description>
    <arm_group_label>Breast Cancer Cases Among Men with Exposure to Finasteride</arm_group_label>
    <other_name>MK-0906</other_name>
    <other_name>PROSCAR速</other_name>
    <other_name>PROPECIA速</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Population-based health and medical registries, prescription registries, and mortality
        registries in Denmark, Finland, Norway, and Sweden
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant's study medical information available in population-based health and
             medical registries, prescription registries, and mortality registries in Denmark,
             Finland, Norway, or Sweden within the observation period of 1995 to 2009

          -  Male with breast cancer with medical information in one of the 4 country-specific
             registries in this study

          -  Study participant's exposure to finasteride is available
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>Denmark</country>
  </removed_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 20, 2014</lastchanged_date>
  <firstreceived_date>September 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Males breast cancer</keyword>
  <keyword>Finasteride</keyword>
  <keyword>PROSCAR速</keyword>
  <keyword>PROPECIA速</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Breast Neoplasms, Male</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Finasteride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
